Tim Belcher

Partner, UK and European Patent Attorney
Leeds
tbelcher@eip.com

Biography

Tim is a UK and European patent attorney with experience in dealing with patents across the chemical field, with a particular focus on pharmaceuticals and biochemistry. He has spent over 2 years on a part-time secondment to the in-house department of one of the largest multinational pharmaceutical companies and is consequently well versed in clients’ commercial considerations and the requirements of in-house counsel. Tim also works closely with start-ups in the pharmaceutical space, where he is able to offer this in-house perspective to smaller enterprises, and to provide guidance on how to optimise IP practices in order to attract investment and maximise exit value. Tim has also worked on cases relating to agrichemicals, food products and ingredients, polymers, industrial processes, materials, medical devices and mechanical inventions.

Tim has significant experience in drafting patent applications and prosecuting them at EPO, JPO and USPTO. Tim also often provides advice to clients on freedom to operate and in due diligence matters. He also typically files several oppositions each year and regularly appears before the EPO at oral hearings (both as patentee and opponent). During qualification as a patent attorney, Tim was awarded the Gill prize for the highest mark in the UK patent attorney qualifying examinations 2012, and the Drafting prize for the highest mark in the UK drafting finals paper. He also achieved amongst the highest marks in the opposition and law papers for the European qualifying examination and regularly provides tutorials to trainees in the profession.

Tim graduated with a first class masters degree in Chemistry from the University of Oxford. During his degree, he spent a year researching quantum cascade laser spectroscopy and the potential to use highly tuneable QCLs to achieve selective excitation in organic syntheses.

Recent Work
  • Drafting new patent applications for GSK, Tate&Lyle and Nanosys, amongst others
  • Advisory work in the area of mRNA vaccines
  • Defensive oppositions for HP Inc. and GSK, and several strawman offensive oppositions. Also, significant due diligence and FTO project for GSK.
Education
  • MSc Chemistry - University of Oxford (2006 — 2010)
Languages Spoken
  • French (Basic)
Career History
  • Partner at EIP (2022 — present)
  • Managing Associate at EIP (2020 — 2022)
  • Senior Associate at EIP (2014 — 2019)
  • Associate at EIP (2014)
  • Technical Assistant at Mewburn Ellis (2010 — 2014)
Specialisms
  • Digital: Medical imaging, Semiconductors
  • Elements: Food & flavour ingredients, Materials science, Petrochemicals, Pharmaceuticals, Polymers, Semiconductors
  • HealthTech: Medical devices, Medical imaging, Surgical tools and implants
  • Life: Agritech, Pharmaceuticals
Awards

The latest from

Tim Belcher

What should you look to protect in a (bio)pharma IP strategy?
18 November 2025
Potential investors and development partners will expect to see an IP portfolio and strategy which maximises protection for the assets under development.
What are the options if you want to avoid the UPC?
03 November 2022
During the transitional period, it is possible to opt classical (i.e. non-unitary) European patents and applications out of the competence of the UPC (provided that no action has commenced at the UPC...
What are the options if you want to be able to use the UPC?
03 November 2022
All unitary patents fall within the competence of the Unified Patent Court (UPC). Additionally, classical validations of European Patents in states which have ratified the UPC agreement are within...

Contact us

Please complete the form below and we will be in touch shortly.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please try again.